Research Programs · Scientific questions, not protocols

Molecule Research by Health Goal

Start with a biological question. Explore how different molecules are studied—and where the evidence stops.

These are educational groupings, not treatment packages, stacks or recommendations to combine molecules. No combination benefit is implied.

Research question 01

Tissue Recovery Research

Can repair signaling translate from the laboratory to human recovery?

BPC-157 has been investigated in tendon, ligament and gastrointestinal injury models. Angiogenesis and growth-factor signaling are proposed mechanisms, not established treatment effects.

Explore our broader optimization program

BPC-157

Repair / angiogenesis

Preclinical

Interactions & unanswered questions

Small reports cannot establish effectiveness, comparative benefit or long-term safety. High-quality controlled human trials are needed.

Research question 02

Advanced Tissue Recovery Research

What separates blood-vessel signaling from cell-migration research?

BPC-157 research discusses vascular and repair signals; related thymosin beta-4 research examines actin and cell migration. TB-500 fragments are not interchangeable with full-length thymosin beta-4.

Explore our broader optimization program

BPC-157

Repair / angiogenesis

Preclinical

TB-500

Actin / cell migration

Preclinical

Interactions & unanswered questions

No robust human evidence establishes this combination as safe or effective. Complementary hypotheses do not demonstrate synergy; interaction risks remain unknown.

Compare these molecules

Research question 03

Metabolic Optimization Research

How do appetite signals differ from growth-hormone signaling?

GLP-1, GIP, glucagon and amylin targets are distinct from tesamorelin’s GHRH pathway. Some finished medications have indication-specific approvals; investigational agents and combinations do not inherit them.

Explore our broader optimization program

Semaglutide

GLP-1 signaling

Human outcomes

Tirzepatide

GLP-1 / GIP signaling

Human outcomes

Retatrutide

GLP-1 / GIP / glucagon

Human research

Cagrilintide

Amylin signaling

Human research

CagriSema

GLP-1 / amylin

Human research

Tesamorelin

GHRH / GH–IGF-1

Human outcomes

Interactions & unanswered questions

These are alternatives and research comparisons, not a regimen. Combining overlapping appetite pathways can increase adverse effects; the CagriSema trials study a particular combination and cannot validate other mixtures.

Compare the first four molecules

Research question 04

Cognitive Performance Research

Does a change in a neural pathway improve cognition in people?

Research explores neurotrophic signaling, stress pathways and synaptic plasticity. Much of the accessible literature is preclinical or limited in independent replication.

Explore our broader optimization program

Semax

ACTH-related / neurotrophic signaling

Limited / uncertain

Selank

Tuftsin-related / neuropeptide signaling

Limited / uncertain

Dihexa

HGF / c-Met

Preclinical

P21

CNTF-related neurotrophic signaling

Limited / uncertain

Interactions & unanswered questions

Biological plausibility does not establish better memory, focus or treatment of neurological disease. Human interaction and long-term neurological safety data are inadequate.

Compare these molecules

Research question 05

Longevity & Cellular Health Research

Are cellular changes the same thing as living longer?

These molecules address different hypotheses: mitochondrial membranes, metabolic stress, telomere biology and senescent cells. Elamipretide’s narrow Barth syndrome approval is not an anti-aging indication.

Explore our broader optimization program

SS-31 / Elamipretide

Cardiolipin / mitochondrial membrane

Human research

MOTS-c

AMPK / mitochondrial metabolism

Preclinical

Epitalon

Telomere / cellular senescence

Preclinical

Humanin

Mitochondrial stress signaling

Preclinical

FOXO4-DRI

FOXO4 / p53 / senescence

Preclinical

Interactions & unanswered questions

No molecule in this grouping is established to extend healthy human lifespan. Combining them has not been shown to improve longevity and may introduce unknown interactions.

Compare the first four molecules

Research question 06

Sleep & Circadian Research

What would convincing evidence of better sleep look like?

Historical DSIP studies, pineal-related epitalon hypotheses and stress-related selank research ask different questions. Valid sleep outcomes include sleep quality, daytime function and objective sleep measures.

Explore our broader optimization program

DSIP

Sleep / neuropeptide signaling

Limited / uncertain

Epitalon

Telomere / cellular senescence

Preclinical

Selank

Tuftsin-related / neuropeptide signaling

Limited / uncertain

Interactions & unanswered questions

Modern independently replicated trials and combination-safety evidence are limited. These entries are not alternatives to evaluation of insomnia, sleep apnea or medication effects.

Compare these molecules

Research question 07

Performance Recovery Research

Does a hormone response demonstrate better performance?

GHRH and ghrelin-receptor signaling can affect GH/IGF-1 biology; IGF analogs and MGF constructs have different mechanisms. Many performance claims go beyond the evidence.

Explore our broader optimization program

CJC-1295

GHRH / GH–IGF-1

Human research

Ipamorelin

Ghrelin / GH–IGF-1

Human research

PEG-MGF

IGF-1 / MGF signaling

Preclinical

IGF-1 LR3

IGF-1 receptor signaling

Preclinical

Interactions & unanswered questions

GH/IGF-1 stimulation is not proof of functional recovery. Overlapping endocrine effects can increase glucose and fluid-balance risks. Athletes must check current anti-doping rules with their governing body.

Compare these molecules

Research question 08

Immune & Gut Research

When does immune signaling help—and when might it harm?

Thymosin alpha-1 research concerns immune regulation, KPV research intestinal inflammatory signaling, and LL-37 research antimicrobial and immune pathways. These actions are context-dependent.

Explore our broader optimization program

Thymosin Alpha-1

T-cell / immune signaling

Human research

KPV

PepT1 / NF-κB

Preclinical

LL-37

Cathelicidin / innate immunity

Human research

Interactions & unanswered questions

Immune activation is not universally beneficial. Interactions with immune-suppressing treatment and effects in autoimmune disease require clinical assessment; no combined benefit is established.

Compare these molecules

Research question 09

Hormonal Signaling Research

Which endocrine axis is actually being studied?

GH secretagogues, reproductive kisspeptin signaling and melanocortin signaling are not interchangeable. Bremelanotide’s approved indication is specific and does not validate other molecules or uses.

Explore our broader optimization program

Sermorelin

GHRH / GH–IGF-1

Human research

CJC-1295

GHRH / GH–IGF-1

Human research

Ipamorelin

Ghrelin / GH–IGF-1

Human research

GHRP-2

Ghrelin / GH–IGF-1

Human research

Kisspeptin-10

KISS1R / GnRH

Human research

PT-141 / Bremelanotide

Melanocortin signaling

Human outcomes

Interactions & unanswered questions

Baseline endocrine disease, cardiovascular risk and other medicines can change safety. Combining upstream hormone signals can have unpredictable downstream effects.

Compare the first four molecules

Research question 10

Skin & Aesthetic Science Research

Why does the route of exposure matter?

Topical copper-peptide research is distinct from systemic exposure. Melanocortin-mediated pigmentation is a different mechanism and does not provide proven protection against UV damage.

Explore our broader optimization program

GHK-Cu

Copper / extracellular matrix

Human research

Melanotan II

Melanocortin signaling

Limited / uncertain

Interactions & unanswered questions

Topical findings cannot establish injectable safety. Melanotan II has serious reported safety signals; this grouping is a scientific comparison, never a recommendation to combine or use these compounds.

Compare these molecules

Beyond the library

Turn better questions into a thoughtful conversation.

Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.

Explore Integrated Wellness Optimization Programs Learn More About Our Clinical Approach

Request an Optimization Consultation

Continue to our existing activation & intake page.